31 A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of a bioengineered allogeneic cellularized construct in patients with deep partial-thickness thermal burns. Issue 1 (1st April 2021) - Gibson, Angela L F; Holmes, James H; Shupp, Jeffrey W; Smith, David; Joe, Victor; Carson, Joshua; Litt, Jeffrey; Kahn, Steven; Short, Tracee; Cancio, Leopoldo; Rizzo, Julie; Carter, Jeffrey E; et al.